Related News:
- New two-year data for Roche’s Vabysmo and Susvimo…
- New two-year data for Roche’s Vabysmo and Susvimo…
- Roche to present new OCREVUS (ocrelizumab) data in…
- Two PerkinElmer Tests Added to UK’s Updated NICE…
- EUROIMMUN Launches Two Assays for the Quantification…
- Roche launches two new antibodies to identify key…